April 2012

New Medications Available…

Rx Outreach is pleased to announce the following list of medications is now available on the Rx Outreach Program.  To order, click here for an application.

  New Medications

Rx Outreach Medication Brand/Generic Equivalent Available Strengths Fee per 90-day Fee per 180-day
Alclometasone Dipropionate Cream Aclovate® 15gm, 45gm $15 per tube
Betamethasone Dipropionate Cream, Augmented Diprolene® AF 15gm, 50gm $25 per tube
Mometasone Furoate Cream Elocon® 15gm, 45gm $15 per tube
Mometasone Furoate Ointment Elocon® 15gm, 45gm $15 per tube
Felodipine ER Tablet Plendil® ER 2.5mg, 5mg $40 up to 90 tablets
Felodipine ER Tablet Plendil® ER 100mg $70 up to 90 tablets
Norethindrone Tablet Ortho Micronor® 28’s (0.35mg) $35.00 $65.00
Norethindrone/Ethinyl Estradiol Tablet Ovcon® 35 28’s (0.4mg/0.035mg) $35.00 $65.00
Norethindrone Acetate Tablet Aygestin® 5mg $75 up to 50 tablets
Pramipexole Tablet Mirapex® 0.125mg, 0.25mg, 0.5mg, 1mg, 1.5mg $25 up to 180 tablets

 

Asthma Affects 22 Million Americans.

Signs of springtime—blooming flowers, blossoming trees, wheezing, coughing…bring misery to allergy and asthma sufferers.   Asthma affects 22 million Americans and causes nearly 2 million emergency room visits each year.  Allergy and asthma symptoms can be controlled, but it takes some planning. To learn more about asthma, click here.

Findings Show Clearly:  Where You Live Matters for Health Care Access

The commonwealth Fund, a private foundation, has released their results from a Scorecard on Local Health Performance, 2012.  It tracks 43 indicators spanning four dimensions of health system performance.  People in the United States, regardless of where they live, deserve the same opportunities to lead long, healthy, and productive lives.  Yet this new Scorecard on Local Health System Performance finds that where one lives has a major impact on the ability to access health care.  The report finds access to care, quality of care, costs, and health outcomes all vary significantly.  To view the report, click here

 

Comments are closed.